{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:27:20Z","timestamp":1791664040285,"version":"4.3.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Early detection of individuals at risk for Alzheimer\u2019s disease (AD) is highly important. Amyloid accumulation is an early pathological AD event, but the genetic association with known AD risk variants beyond the\n                      <jats:italic>APOE4<\/jats:italic>\n                      effect is largely unknown. We investigated the association between different AD polygenic risk scores (PRS) and amyloid accumulation in the Flemish Prevent AD Cohort KU Leuven (F-PACK).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We calculated PRS with and without the\n                      <jats:italic>APOE<\/jats:italic>\n                      region in 90 cognitively healthy F-PACK participants (baseline age 67.8 (52\u201380) years, 41\n                      <jats:italic>APOE4<\/jats:italic>\n                      carriers), with baseline and follow-up amyloid-PET (time interval 6.1 (3.4\u201310.9) years). Individuals were genotyped using Illumina GSA and imputed. PRS were calculated using three\n                      <jats:italic>p<\/jats:italic>\n                      -value thresholds (pT) for variant inclusion: 5\u2009\u00d7\u200910\n                      <jats:sup>\u22128<\/jats:sup>\n                      , 1\u2009\u00d7\u200910\n                      <jats:sup>\u22125<\/jats:sup>\n                      , and 0.1, based on the stage 1 summary statistics from Kunkle et al. (Nat Genet 51:414\u201330, 2019). Linear regression models determined if these PRS predicted amyloid accumulation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A score based on PRS excluding the\n                      <jats:italic>APOE<\/jats:italic>\n                      region at pT\u2009=\u20095\u2009\u00d7\u200910\n                      <jats:sup>\u22128<\/jats:sup>\n                      plus the weighted sum of the two major\n                      <jats:italic>APOE<\/jats:italic>\n                      variants (rs429358 and rs7412) was significantly associated with amyloid accumulation (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0126). The two major\n                      <jats:italic>APOE<\/jats:italic>\n                      variants were also significantly associated with amyloid accumulation (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0496). The other PRS were not significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Specific PRS are associated with amyloid accumulation in the asymptomatic phase of AD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-022-01079-4","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T08:03:44Z","timestamp":1663920224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Association of Alzheimer\u2019s disease polygenic risk scores with amyloid accumulation in cognitively intact older adults"],"prefix":"10.1186","volume":"14","author":[{"given":"Emma S.","family":"Luckett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmina","family":"Abakkouy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariska","family":"Reinartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Adamczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolien","family":"Schaeverbeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sare","family":"Verstockt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffi","family":"De Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Van Laere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Cleynen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"1079_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","volume":"63","author":"M Gatz","year":"2006","unstructured":"Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, et al. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry. 2006;63:168\u201374 American Medical Association.","journal-title":"Arch Gen Psychiatry"},{"key":"1079_CR2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, et al. Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: A prospective cohort study. Lancet Neurol. 2013;12:357\u201367.","journal-title":"Lancet Neurol"},{"key":"1079_CR3","doi-asserted-by":"publisher","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010;9(1):119\u201328. https:\/\/doi.org\/10.1016\/S1474-4422(09)70299-6.","DOI":"10.1016\/S1474-4422(09)70299-6"},{"key":"1079_CR4","first-page":"921","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science (1979). 1993;261:921\u20133 American Association for the Advancement of Science.","journal-title":"Science (1979)"},{"key":"1079_CR5","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.biopsych.2010.05.013","volume":"68","author":"T Grimmer","year":"2010","unstructured":"Grimmer T, Tholen S, Yousefi BH, Alexopoulos P, F\u00f6rschler A, F\u00f6rstl H, et al. Progression of cerebral amyloid load is associated with the apolipoprotein e \u03b54 genotype in Alzheimer\u2019s disease. Biol Psychiatry. 2010;68:879\u201384 NIH Public Access.","journal-title":"Biol Psychiatry"},{"key":"1079_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ana.22248","volume":"69","author":"VL Villemagne","year":"2011","unstructured":"Villemagne VL, Pike KE, Ch\u00e9telat G, Ellis KA, Mulligan RS, Bourgeat P, et al. Longitudinal assessment of A\u03b2 and cognition in aging and Alzheimer disease. Ann Neurol. 2011;69:181\u201392 NIH Public Access.","journal-title":"Ann Neurol"},{"key":"1079_CR7","doi-asserted-by":"publisher","unstructured":"Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15(9):501\u201318. https:\/\/doi.org\/10.1038\/s41582-019-0228-7.","DOI":"10.1038\/s41582-019-0228-7"},{"key":"1079_CR8","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1212\/WNL.0b013e3182840bbe","volume":"80","author":"CR Jack","year":"2013","unstructured":"Jack CR, Wiste HJ, Lesnick TG, Weigand SD, Knopman DS, Vemuri P, et al. Brain \u03b2-amyloid load approaches a plateau. Neurology. 2013;80:890\u20136 American Academy of Neurology.","journal-title":"Neurology"},{"key":"1079_CR9","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet. 2013;45:1452 NIH Public Access.","journal-title":"Nat Genet"},{"key":"1079_CR10","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat Genet. 2019;51:404\u201313 Nature Publishing Group.","journal-title":"Nat Genet"},{"issue":"3","key":"1079_CR11","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat Genet. 2019;51(3):414\u201330 [cited 2021 Dec 20], Nature Publishing Group; Available from: https:\/\/www.nature.com\/articles\/s41588-019-0358-2.","journal-title":"Nat Genet"},{"key":"1079_CR12","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/s41588-021-00921-z","volume":"53","author":"DP Wightman","year":"2021","unstructured":"Wightman DP, Jansen IE, Savage JE, Shadrin AA, Bahrami S, Holland D, et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer\u2019s disease. Nat Genet. 2021;53:1276\u201382.","journal-title":"Nat Genet"},{"key":"1079_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet. 2022;54:1\u201325 Nature Publishing Group; [cited 2022 Apr 13]. Available from: https:\/\/www.nature.com\/articles\/s41588-022-01024-z.","journal-title":"Nat Genet"},{"key":"1079_CR14","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.jalz.2015.02.013","volume":"11","author":"K Sleegers","year":"2015","unstructured":"Sleegers K, Bettens K, De Roeck A, Van Cauwenberghe C, Cuyvers E, Verheijen J, et al. A 22-single nucleotide polymorphism Alzheimer\u2019s disease risk score correlates with family history, onset age, and cerebrospinal fluid A\u03b242. Alzheimer\u2019s Dement. 2015;11:1452\u201360 Elsevier Inc.","journal-title":"Alzheimer\u2019s Dement"},{"key":"1079_CR15","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1093\/brain\/awv268","volume":"138","author":"V Escott-Price","year":"2015","unstructured":"Escott-Price V, Sims R, Bannister C, Harold D, Vronskaya M, Majounie E, et al. Common polygenic variation enhances risk prediction for Alzheimer\u2019s disease. Brain. 2015;138:3673\u201384 [cited 2019 Nov 29]. Available from: https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/awv268.","journal-title":"Brain."},{"key":"1079_CR16","first-page":"16","volume":"6","author":"V Escott-Price","year":"2019","unstructured":"Escott-Price V, Myers A, Huentelman M, Shoai M, Hardy J. Polygenic risk score analysis of Alzheimer\u2019s disease in cases without APOE4 or APOE2 alleles. J Prev Alzheimers Dis NLM (Medline). 2019;6:16\u20139.","journal-title":"J Prev Alzheimers Dis NLM (Medline)"},{"key":"1079_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13993-7","volume":"11","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Sidorenko J, Couvy-Duchesne B, Marioni RE, Wright MJ, Goate AM, et al. Risk prediction of late-onset Alzheimer\u2019s disease implies an oligogenic architecture. Nat Commun. 2020;11:1\u201311 Nature Research.","journal-title":"Nat Commun"},{"key":"1079_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-24082-z","volume":"12","author":"G Leonenko","year":"2021","unstructured":"Leonenko G, Baker E, Stevenson-Hoare J, Sierksma A, Fiers M, Williams J, et al. Identifying individuals with high risk of Alzheimer\u2019s disease using polygenic risk scores. Nat Commun. 2021;12:1\u201310 Nature Publishing Group; [cited 2021 Aug 5]. Available from: https:\/\/www.nature.com\/articles\/s41467-021-24082-z.","journal-title":"Nat Commun"},{"key":"1079_CR19","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.nicl.2013.04.001","volume":"2","author":"K Adamczuk","year":"2013","unstructured":"Adamczuk K, De Weer AS, Nelissen N, Chen K, Sleegers K, Bettens K, et al. Polymorphism of brain derived neurotrophic factor influences \u03b2 amyloid load in cognitively intact apolipoprotein \u03b54 carriers. NeuroImage: Clin. 2013;2:512\u201320 Elsevier.","journal-title":"NeuroImage: Clin"},{"key":"1079_CR20","doi-asserted-by":"publisher","unstructured":"Schaeverbeke JM, Gabel S, Meersmans K, et al. Baseline cognition is the best predictor of 4-year cognitive change in cognitively intact older adults. Alz Res Therapy. 2021;13:75. https:\/\/doi.org\/10.1186\/s13195-021-00798-4.","DOI":"10.1186\/s13195-021-00798-4"},{"key":"1079_CR21","doi-asserted-by":"publisher","first-page":"818","DOI":"10.2967\/jnumed.108.060756","volume":"50","author":"M Koole","year":"2009","unstructured":"Koole M, Lewis DM, Buckley C, Nelissen N, Vandenbulcke M, Brooks DJ, et al. Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging. J Nucl Med. 2009;50:818\u201322 Society of Nuclear Medicine.","journal-title":"J Nucl Med"},{"key":"1079_CR22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ana.22068","volume":"68","author":"R Vandenberghe","year":"2010","unstructured":"Vandenberghe R, Van Laere K, Ivanoiu A, Salmon E, Bastin C, Triau E, et al. 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment a phase 2 trial. Ann Neurol. 2010;68:319\u201329.","journal-title":"Ann Neurol"},{"key":"1079_CR23","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.neuroimage.2012.09.015","volume":"64","author":"R Vandenberghe","year":"2013","unstructured":"Vandenberghe R, Nelissen N, Salmon E, Ivanoiu A, Hasselbalch S, Andersen A, et al. Binary classification of 18F-flutemetamol PET using machine learning: Comparison with visual reads and structural MRI. Neuroimage. 2013;64:517\u201325.","journal-title":"Neuroimage."},{"key":"1079_CR24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s00259-015-3156-9","volume":"43","author":"K Adamczuk","year":"2016","unstructured":"Adamczuk K, Schaeverbeke J, Nelissen N, Neyens V, Vandenbulcke M, Goffin K, et al. Amyloid imaging in cognitively normal older adults: comparison between 18F-flutemetamol and 11C-Pittsburgh compound B. Eur J Nucl Med Mol Imaging. 2016;43:142\u201351 springer berlin.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1079_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/nimg.2001.0978","volume":"15","author":"N Tzourio-Mazoyer","year":"2002","unstructured":"Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002;15:273\u201389.","journal-title":"Neuroimage."},{"key":"1079_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","volume":"11","author":"WE Klunk","year":"2015","unstructured":"Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD, Jagust WJ, et al. The Centiloid project: standardizing quantitative amyloid plaque estimation by PET. Alzheimer\u2019s Dement. 2015;11:1\u201315.e4 Wiley.","journal-title":"Alzheimer\u2019s Dement"},{"key":"1079_CR27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13195-020-00728-w","volume":"12","author":"S De Meyer","year":"2020","unstructured":"De Meyer S, Schaeverbeke JM, Verberk IMW, Gille B, De Schaepdryver M, Luckett ES, et al. Comparison of ELISA- and SIMOA-based quantification of plasma A\u03b2 ratios for early detection of cerebral amyloidosis. Alzheimer\u2019s Res Ther. 2020;12:162 BioMed Central Ltd.","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"1079_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jalz.2018.09.001","volume":"15","author":"R la Joie","year":"2019","unstructured":"la Joie R, Ayakta N, Seeley WW, Borys E, Boxer AL, DeCarli C, et al. Multisite study of the relationships between antemortem [ 11 C]PIB-PET Centiloid values and postmortem measures of Alzheimer\u2019s disease neuropathology. Alzheimer\u2019s Dement. 2019;15:205\u201316 NIH Public Access; [cited 2021 Nov 5]. Available from: \/pmc\/articles\/PMC6368897\/.","journal-title":"Alzheimer\u2019s Dement"},{"key":"1079_CR29","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/jcbfm.1992.81","volume":"12","author":"HW M\u00fcller-G\u00e4rtner","year":"1992","unstructured":"M\u00fcller-G\u00e4rtner HW, Links JM, Prince JL, Bryan RN, McVeigh E, Leal JP, et al. Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J Cereb Blood Flow Metab. 1992;12:571\u201383 SAGE Publications Sage UK: London, England.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1079_CR30","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0022-5371(73)80034-9","volume":"12","author":"H Buschke","year":"1973","unstructured":"Buschke H. Selective reminding for analysis of memory and learning. J Verbal Learn Verbal Behav. 1973;12:543\u201350 Academic Press.","journal-title":"J Verbal Learn Verbal Behav"},{"key":"1079_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v048.i02","volume":"48","author":"Y Rosseel","year":"2012","unstructured":"Rosseel Y. Lavaan: An R package for structural equation modeling. J Stat Softw. 2012;48:1\u201336 American Statistical Association.","journal-title":"J Stat Softw"},{"key":"1079_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S van Buuren","year":"2011","unstructured":"van Buuren S, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45:1\u201367.","journal-title":"J Stat Softw"},{"key":"1079_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-020-01074-z","volume":"10","author":"S Hong","year":"2020","unstructured":"Hong S, Prokopenko D, Dobricic V, Kilpert F, Bos I, Vos SJB, et al. Genome-wide association study of Alzheimer\u2019s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset. Transl Psychiatry. 2020;10:1\u201312 Nature Publishing Group.","journal-title":"Transl Psychiatry"},{"key":"1079_CR34","doi-asserted-by":"publisher","first-page":"e1608","DOI":"10.1002\/mpr.1608","volume":"27","author":"AT Marees","year":"2018","unstructured":"Marees AT, de Kluiver H, Stringer S, Vorspan F, Curis E, Marie-Claire C, et al. A tutorial on conducting genome-wide association studies: quality control and statistical analysis. Int J Methods Psychiatr Res. 2018;27:e1608 Wiley.","journal-title":"Int J Methods Psychiatr Res"},{"key":"1079_CR35","doi-asserted-by":"publisher","unstructured":"1000 Genomes Project Consortium, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL, McCarthy S, McVean GA, Abecasis GR. A global reference for human genetic variation. Nature. 2015;526(7571):68\u201374. https:\/\/doi.org\/10.1038\/nature15393.","DOI":"10.1038\/nature15393"},{"key":"1079_CR36","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.3656","volume":"48","author":"S Das","year":"2016","unstructured":"Das S, Forer L, Sch\u00f6nherr S, Sidore C, Locke AE, Kwong A, et al. Next-generation genotype imputation service and methods. Nat Genet. 2016;48:1284\u20137 NIH Public Access.","journal-title":"Nat Genet"},{"key":"1079_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/gigascience\/giz082","volume":"8","author":"SW Choi","year":"2019","unstructured":"Choi SW, O\u2019Reilly PF. PRSice-2: Polygenic Risk Score software for biobank-scale data. Gigascience. 2019;8:1\u20136 Oxford University Press.","journal-title":"Gigascience"},{"key":"1079_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:1\u20138 BioMed Central.","journal-title":"BMC Bioinformatics"},{"key":"1079_CR39","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837\u201345.","journal-title":"Biometrics."},{"key":"1079_CR40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1006\/nimg.1996.0248","volume":"5","author":"JB Poline","year":"1997","unstructured":"Poline JB, Worsley KJ, Evans AC, Friston KJ. Combining spatial extent and peak intensity to test for activations in functional imaging. Neuroimage. 1997;5:83\u201396.","journal-title":"Neuroimage."},{"key":"1079_CR41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3233\/JAD-180749","volume":"67","author":"CG Schwarz","year":"2019","unstructured":"Schwarz CG, Gunter JL, Lowe VJ, Weigand S, Vemuri P, Senjem ML, et al. A comparison of partial volume correction techniques for measuring change in serial amyloid pet SUVR. J Alzheimers Dis. 2019;67:181\u201395 IOS Press;[cited 2022 Apr 8]. Available from: \/pmc\/articles\/PMC6398556\/.","journal-title":"J Alzheimers Dis"},{"key":"1079_CR42","doi-asserted-by":"publisher","first-page":"E1605","DOI":"10.1212\/WNL.0000000000005415","volume":"90","author":"T Ge","year":"2018","unstructured":"Ge T, Sabuncu MR, Smoller JW, Sperling RA, Mormino EC. Dissociable influences of APOE e4 and polygenic risk of AD dementia on amyloid and cognition. Neurology. 2018;90:E1605\u201312 American Academy of Neurology.","journal-title":"Neurology"},{"key":"1079_CR43","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ana.25530","volume":"86","author":"G Leonenko","year":"2019","unstructured":"Leonenko G, Shoai M, Bellou E, Sims R, Williams J, Hardy J, et al. Genetic risk for Alzheimer disease is distinct from genetic risk for amyloid deposition. Ann Neurol. 2019;86:427\u201335 Wiley-Blackwell.","journal-title":"Ann Neurol"},{"key":"1079_CR44","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1093\/brain\/awy103","volume":"141","author":"S Mishra","year":"2018","unstructured":"Mishra S, Blazey TM, Holtzman DM, Cruchaga C, Su Y, Morris JC, et al. Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE \u03f54 genotype. Brain. 2018;141:1828\u201339 Oxford University Press.","journal-title":"Brain"},{"key":"#cr-split#-1079_CR45.1","doi-asserted-by":"crossref","unstructured":"Sojkova J, Goh J, Bilgel M, Landman B, Yang X, Zhou Y, et al. Voxel-wise relationships between distribution volume ratio and cerebral blood flow: implications for analysis of \u03b2-amyloid images. J Nucl Med. 2015;56:1042 NIH Public Access","DOI":"10.2967\/jnumed.114.151480"},{"key":"#cr-split#-1079_CR45.2","unstructured":"[cited 2022 Jul 11]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5367770\/."},{"key":"#cr-split#-1079_CR46.1","doi-asserted-by":"crossref","unstructured":"Heeman F, Yaqub M, Lopes Alves I, Heurling K, Bullich S, Gispert JD, et al. Simulating the effect of cerebral blood flow changes on regional quantification of [18F]flutemetamol and [18F]florbetaben studies. J Cereb Blood Flow Metab. 2021;41:579 SAGE Publications","DOI":"10.1177\/0271678X20918029"},{"key":"#cr-split#-1079_CR46.2","unstructured":"[cited 2022 Jul 11]. Available from:\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7907983\/."}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-01079-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-022-01079-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-01079-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T23:30:40Z","timestamp":1664062240000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-022-01079-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1079"],"URL":"https:\/\/doi.org\/10.1186\/s13195-022-01079-4","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"assertion":[{"value":"25 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was approved by the Ethics Committee University Hospitals Leuven. All participants provided written informed consent in accordance with the declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RV has received research grants from Research Foundation\u2014Flanders (FWO) and KU Leuven, has had a clinical trial agreement for phase 1 and 2 study between University Hospitals Leuven and GE-HC, has received a non-financial support from GE-HC (provision of <sup>18<\/sup>F-Flutemetamol for conduct of investigator-driven trial free of cost), and has a clinical trial agreement (local principal investigator) between University Hospitals Leuven and Biogen, J&J, NovoNordisk, Roche, and UCB.KVL has received research grants from FWO and KU Leuven, has clinical trial agreements through University Hospitals Leuven\/KU Leuven and J&J, Merck, BMS, GE Healthcare, CHDI, Cerveau, Eikonizo, Lundbeck, UCB and Curasen.ESL, YA, MR, KA, JS, SV, SDM, PD, and IC have no disclosers.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"138"}}